Skip to main content

UK life sciences industry grapples with new questions from Brexit spanning funding, regulatory landscape – MedCity News

By June 29, 2016News
brexit-britain-european-union-pixa

brexit-britain-european-union-pixa

Last week, Great Britain voted to leave the European Union of 28 member states, or “Brexit.” Since the result was announced sterling has fallen to a 31-year low, there has been a record daily drop in  global equity markets and political turmoil has broken out as the UK Prime Minister has said he will step down and the majority of the leadership team of the official opposition party has resigned.

{iframe}http://medcitynews.com/2016/06/uk-life-sciences-and-brexit/?utm_source=MedCity+News+Subscribers&utm_campaign=289e0ee7e5-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-289e0ee7e5-408826397{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.